Shyam Sundar
Shyam Sundar
Distinguished Professor of Medicine, Banaras Hindu University
Verified email at
Cited by
Cited by
Drug resistance in leishmaniasis
SL Croft, S Sundar, AH Fairlamb
Clinical microbiology reviews 19 (1), 111-126, 2006
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
F Chappuis, S Sundar, A Hailu, H Ghalib, S Rijal, RW Peeling, J Alvar, ...
Nature reviews microbiology 5 (11), 873-882, 2007
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
PJ Guerin, P Olliaro, S Sundar, M Boelaert, SL Croft, P Desjeux, ...
The Lancet infectious diseases 2 (8), 494-501, 2002
Oral miltefosine for Indian visceral leishmaniasis
S Sundar, TK Jha, CP Thakur, J Engel, H Sindermann, C Fischer, K Junge, ...
New England journal of medicine 347 (22), 1739-1746, 2002
Laboratory diagnosis of visceral leishmaniasis
S Sundar, M Rai
Clinical and vaccine immunology 9 (5), 951-958, 2002
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic
S Sundar, DK More, MK Singh, VP Singh, S Sharma, A Makharia, ...
Clinical infectious diseases 31 (4), 1104-1107, 2000
Drug resistance in Indian visceral leishmaniasis
S Sundar
Tropical Medicine & International Health 6 (11), 849-854, 2001
Antimony toxicity
S Sundar, J Chakravarty
International journal of environmental research and public health 7 (12á…, 2010
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
TK Jha, S Sundar, CP Thakur, P Bachmann, J Karbwang, C Fischer, ...
New England Journal of Medicine 341 (24), 1795-1800, 1999
Injectable paromomycin for visceral leishmaniasis in India
S Sundar, TK Jha, CP Thakur, PK Sinha, SK Bhattacharya
New England Journal of Medicine 356 (25), 2571-2581, 2007
Evidence that the High Incidence of Treatment Failures in Indian Kala-Azar Is Due to the Emergence of Antimony-Resistant Strains of Leishmania donovani
R Lira, S Sundar, A Makharia, R Kenney, A Gam, E Saraiva, D Sacks
The Journal of infectious diseases 180 (2), 564-567, 1999
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
T Downing, H Imamura, S Decuypere, TG Clark, GH Coombs, JA Cotton, ...
Genome research 21 (12), 2143-2156, 2011
Leishmaniasis: new approaches to disease control
CR Davies, P Kaye, SL Croft, S Sundar
Bmj 326 (7385), 377-382, 2003
Single-dose liposomal amphotericin B for visceral leishmaniasis in India
S Sundar, J Chakravarty, D Agarwal, M Rai, HW Murray
New England Journal of Medicine 362 (6), 504-512, 2010
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis
S NylÚn, R Maurya, L Eidsmo, KD Manandhar, S Sundar, D Sacks
The Journal of experimental medicine 204 (4), 805-817, 2007
Liposomal amphotericin B for the treatment of visceral leishmaniasis
LD Saravolatz, C Bern, J Adler-Moore, J Berenguer, M Boelaert, ...
Clinical Infectious Diseases 43 (7), 917-924, 2006
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
S Sundar, PK Sinha, M Rai, DK Verma, K Nawin, S Alam, J Chakravarty, ...
The Lancet 377 (9764), 477-486, 2011
Rapid accurate field diagnosis of Indian visceral leishmaniasis
S Sundar, SG Reed, VP Singh, PCK Kumar, HW Murray
The Lancet 351 (9102), 563-565, 1998
Diagnosis of visceral leishmaniasis
P Srivastava, A Dayama, S Mehrotra, S Sundar
Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (1), 1-6, 2011
Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin
B Gourbal, N Sonuc, H Bhattacharjee, D Legare, S Sundar, M Ouellette, ...
Journal of Biological Chemistry 279 (30), 31010-31017, 2004
The system can't perform the operation now. Try again later.
Articles 1–20